British HIV Association guidelines for the management of HIV infection in pregnant women 2012

HIV Med. 2012 Sep;13 Suppl 2:87-157. doi: 10.1111/j.1468-1293.2012.01030_2.x.


The overall purpose of these guidelines is to provide guidance on best clinical practice in the treatment and management of human immunodeficiency virus (HIV)-positive pregnant women in the UK. The scope includes guidance on the use of antiretroviral therapy (ART) both to prevent HIV mother-to-child transmission (MTCT) and for the welfare of the mother herself, guidance on mode of delivery and recommendations in specific patient populations where other factors need to be taken into consideration,such as coinfection with other agents. The guidelines are aimed at clinical professionals directly involved with, and responsible for, the care of pregnant women with HIV infection.

Publication types

  • Practice Guideline

MeSH terms

  • Adult
  • Anti-HIV Agents / therapeutic use*
  • Antiretroviral Therapy, Highly Active
  • Delivery, Obstetric / methods
  • Female
  • HIV Infections / drug therapy*
  • HIV-1
  • Humans
  • Infectious Disease Transmission, Vertical / prevention & control*
  • Pregnancy
  • Societies, Medical
  • United Kingdom


  • Anti-HIV Agents